Ray Chun-Fai Chan

  • Studentship in 2003 at the Hong Kong University of Science and Technology

Dr. Ray Chun-Fai Chan is currently a Technical Director at Northern California Kaiser Permanente Regional Laboratory in Department of Flow Cytometry. He received his B.Sc. in Biochemistry at Hong Kong University of Science and Technology in 2000. With the support from Croucher Studentship in 2003, Dr. Chan received his Ph.D. at Hong Kong University of Science and Technology in 2004 and his research interest is cancer vaccine, allergy and immunology. He then received his postdoctoral training focusing on the effect of air pollutants on allergic asthma at University of California, Los Angeles (UCLA) in 2004-2007. After that, Dr. Chan was a Research Scientist at multiple pharmaceutical companies and working on clinical trials of DNA-based and cell-based cancer vaccines in 2007-2010.  Before joining BD, he was a Director of Immunology at a pharmaceutical company monitoring novel cell-based cancer vaccine for advanced stage cancer patients under GMP environment.

In 2011, Dr. Chan received an offer from a fortune 500 company, BD Biosciences, as a Custom Applications Scientist working on custom reagents for flow cytometry. He was focusing on customizing multicolor flow cytometry reagents (up to 17-color), assay development, troubleshooting and sample testing for customers. He was also managing his team to manufacture lyophilized reagents for clinical applications. Dr. Chan received his Specialist in Cytometry (SCYM) certification through American Society for Clinical Pathology (ASCP) in 2014. 

In 2016, Dr. Chan moved to Northern California and working at Kaiser Permanente Regional Laboratory as a Research Scientist I Investigator in optimizing flow cytometry panels on blood disorders, Leukemia and Lymphoma. In 2017, Dr. Chan enrolled a Clinical Laboratory Scientist (CLS) program at San Francisco State University (SFSU) and received his California Clinical Chemist Scientist (CCS) license and Technologist in Chemistry certification C(ASCP) in March 2018. He was then promoted to Technical Director in managing all technical aspects in flow cytometry department at Northern California Kaiser Permanente Regional Laboratory.